INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JinkoSolar Holding Co., Ltd.

Pomerantz LLP is investigating potential securities-fraud claims involving JinkoSolar after a $200M-plus non-cash impairment contributed to a $214.5M GAAP loss in Q4 2025 and a subsequent Q2 2026 earnings miss. JinkoSolar's gross margin fell to 4.2% from 8.3% sequentially amid lower solar selling prices, weaker Chinese utility-scale demand and premium-product ramp costs. The ADR declined 11.89% on April 16 to $21.34 and another 11.87% on August 26 to $13.66.

Analysis

The litigation notice is not itself a new fundamental catalyst; the investable issue is that JKS has little demonstrated margin buffer against module-price deflation while premium-product ramp costs remain elevated. A sub-5% gross-margin business has limited capacity to absorb further ASP declines, warranty charges, inventory write-downs, or adverse FX without renewed cash burn and potential balance-sheet pressure. The next 1-3 months should be driven by evidence of Chinese demand normalization and whether quarterly shipment growth can outpace the deterioration in revenue per watt.

Competitive dispersion matters more than the broad solar-beta read-through. JKS, CSIQ and other China-linked module manufacturers remain exposed to global oversupply, whereas FSLR's contracted U.S. backlog, domestic-content economics and differentiated thin-film product should make it a relative beneficiary if commoditized silicon-module pricing remains weak. Upstream suppliers such as DQ face a separate risk: continued module distress raises the probability that manufacturers curtail output rather than replenish polysilicon inventories, extending pricing pressure through the supply chain.

Consensus may overreact to the legal headline after the ADR's prior repricing; securities-firm investigations frequently generate limited direct cash cost absent a filed case, certification, discovery, or a settlement. The more relevant downside is a second impairment or a going-concern-style shift in capital-allocation language at the next earnings release. The bearish thesis is falsified by a sustained gross-margin recovery above roughly 8%, stable operating cash flow after working capital, and management guidance indicating ASP stabilization rather than merely higher shipment volume.

Key Decisions for Investors

• Maintain an underweight/short bias in JKS only on rallies into the next earnings event rather than chase litigation-driven weakness; target a 15-25% downside over 1-3 months if gross margin remains below 5% or management cuts volume/ASP expectations. Cover if gross margin exceeds 8% with positive operating cash flow, as the low valuation can produce sharp short-covering.
• Express relative quality dispersion through long FSLR / short JKS in equal dollar amounts over a 3-6 month horizon. FSLR's U.S.-oriented contracted economics should be less exposed to spot module deflation; key risk is a broad solar-policy reversal or meaningful deterioration in FSLR bookings/backlog pricing.
• Avoid treating the Pomerantz notice as a standalone short catalyst. Escalate legal-risk positioning only if a formal complaint identifies contemporaneous internal documents, an auditor issue, a restatement, or an SEC inquiry; absent those developments, expected litigation cost is unlikely to dominate the operating-margin question.
• Monitor DQ and CSIQ as confirmation indicators rather than immediate recommendations: further polysilicon price weakness, inventory build, or Chinese production curtailments would reinforce the JKS downside case; an industry-wide capacity-cut announcement would be the signal to reduce China-solar shorts.